{
  "url": "https://openlegislation.uk/veterinary-medicines-regulations-2007/note",
  "json_url": "https://openlegislation.uk/veterinary-medicines-regulations-2007/note.json",
  "legislation": "uksi/2007/2539",
  "legislation_title": "The Veterinary Medicines Regulations 2007",
  "legislation_url": "https://openlegislation.uk/veterinary-medicines-regulations-2007",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Regulations)\nThese Regulations revoke and remake with amendments the Veterinary Medicines Regulations 2006.\nPrincipal changes to the 2006 Regulations\nThe new Regulations introduce a requirement for the registration of veterinary premises for the supply of veterinary medicinal products.\nThey implement Commission Directive 2006/130/EC and enforce Commission Regulation (EC) No 1950/2006.\nThey permit the advertising of POM-V medicines to veterinary nurses.\nThey extend the provision that the holder of a Marketing Authorisation for an immunological product must submit to the Secretary of State the results of all tests carried out on each batch of the product before he places the product on the market, to require that the holder must wait for confirmation from the Secretary of State before the product is placed on the market.\nThey control exports to other member States.\nThey update fees.\nThe Regulations\nThe Regulations make provision for the authorisation, manufacture, classification, distribution and administration of veterinary medicinal products.\nThey implement Directive 2001/82/EC.\nThey enforce Regulations (EC) No. 178/2002, No. 1831/2003, No. 882/2004, No. 183/2005, in so far as they apply to veterinary medicinal products used in feedingstuffs, and to some specified feed additives used in feedingstuffs.\nThey implement Council Directive 90/167 so far it is not superseded by Regulation (EC) No. 183/2005.\nThey provide that a veterinary medicinal product must have a marketing authorisation granted by the Secretary of State before being placed on the market, and make provision for the grant of a marketing authorisation (regulation 4 and Schedule 1).\nThey specify that a veterinary medicinal product must be manufactured by a person holding a manufacturing authorisation, and make provision for granting an authorisation (regulation 5 and Schedule 2).\nThey regulate supply and possession of veterinary medicinal products, and introduce new classifications of those products (regulation 7 and Schedule 3).\nThey provide that a veterinary medicinal product may only be administered as specified in its marketing authorisation or, in the case of administration by a veterinary surgeon, administration under the “cascade”” (regulation 8 and Schedule 4).\nThey control bringing a veterinary medicinal product into the United Kingdom (regulation 9) and advertising (regulation 10 to 12).\nThey control wholesale dealing (regulation 13).\nThey control medicated feedingstuffs and feedingstuffs containing additives specified in the Regulations (regulation 14 and Schedule 5).\nThey provide for exemptions (regulation 15 and Schedule 6).\nThey provide for fees (regulation 16 and Schedule 7).\nThey require records to be kept (regulations 17 to 24).\nThey create offences of importation, possession and supply of unauthorised veterinary medicinal products (regulations 25 to 27).\nThey make provision for the existence of the Veterinary Products Committee (regulation 28).\nThey make provision for an appeals procedure in the case of a refusal, etc., of a marketing authorisation (regulation 29).\nThey create administrative arrangements for the enforcement of the Regulations (regulations 32 to 41).\nUnder regulation 42 breach of the Regulations is an offence punishable—\n(a) on summary conviction, to a fine not exceeding the statutory maximum or to imprisonment for a term not exceeding three months or both, or\n(b) on conviction on indictment, to a fine or to imprisonment for a term not exceeding two years or both.\nA Regulatory Impact Assessment has been prepared and placed in the libraries of both Houses of Parliament. It is available, together with a transposition note and a table showing fee changes, on www.vmd.gov.uk at “Publications, Veterinary Medicines Regulations and Guidance”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2007/2539/note",
    "retrieved_at": "2026-10-29T03:44:29.692897+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}